Literature DB >> 3884203

Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives.

L Truedsson, A G Sjöholm, G Sturfelt.   

Abstract

Complement (C) activating rheumatoid factors (RF) were measured in 16 patients with rheumatoid arthritis (RA) by a simple haemolysis in gel (HIG) assay. IgM-RF, but not IgG-RF or IgA-RF, measured by an enzyme linked immuno-sorbent assay, were closely correlated with C activating RF (r = 0.86). In neither assay did the concentrations of RF appear to be directly related to C1 activation as expressed by serum concentrations of C1r-C1s-C1 inactivator complexes or of C4. In the sera, C1q binding substances, measured by C1q binding assay, were markedly correlated with C activating RF (r = 0.88), whereas C1q binding substances detected by the C1q deviation test were not. Treatment with podophyllotoxin derivatives for 6 months clearly reduced patients' RF concentrations. The decrease of IgG-RF, IgA-RF and IgM-RF was significantly more pronounced than that of the IgG, IgA and IgM concentrations, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884203

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Is measurement of rheumatoid factor isotypes clinically useful?

Authors:  T Jónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

2.  Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.

Authors:  E Lindqvist; T Saxne; P Geborek; K Eberhardt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

3.  Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

Authors:  K B Eberhardt; L Truedsson; H Pettersson; B Svensson; L Stigsson; J L Eberhardt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

4.  Mortality in rheumatoid arthritis patients with disease onset in the 1980s.

Authors:  E Lindqvist; K Eberhardt
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

5.  Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study.

Authors:  A Kuuliala; K Eberhardt; A Takala; H Kautiainen; H Repo; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

6.  Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.

Authors:  A J Geirsson; G Sturfelt; L Truedsson
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

7.  Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis.

Authors:  K Eberhardt; E Fex; U Johnson; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

8.  Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.

Authors:  E Lindqvist; K Jonsson; T Saxne; K Eberhardt
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.